Abbott Laboratories
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | $3.39B | $21.53B | $4.06B |
| FY2015 | $5.87B | $21.21B | $5.00B |
| FY2016 | $20.68B | $20.54B | $18.62B |
| FY2017 | $27.21B | $30.90B | $9.41B |
| FY2018 | $19.36B | $30.52B | $3.84B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | $3.39B | $21.53B | $4.06B |
| FY2015 | $5.87B | $21.21B | $5.00B |
| FY2016 | $20.68B | $20.54B | $18.62B |
| FY2017 | $27.21B | $30.90B | $9.41B |
| FY2018 | $19.36B | $30.52B | $3.84B |